No products in the cart.

Up to 52%

Tirzepatide | (GIP/GLP-1 Dual Agonist)

Categories:

Price range: $41 through $300

Now shipping:
99.6% purity | 6.56 mg (5 mg)
99.9% purity | 13.24 mg (12 mg)
99.7% purity | 18.55 mg (15 mg)
99.7% purity | 24.00 mg (20 mg)
99.8% purity | 34.22 mg (30 mg)
99.8% purity | 43.97 mg (40 mg)
99.7% purity | 62.39 mg (60 mg)

CAS NO:2023788-19-2
Sequence Type:YXEGTFTSDY SIXLDKIAQK AFVQWLIAGG PSSGAPPPS
Molecular Formula:  C225H348N48O68
Molecular Weight:  4813.53 Da
Appearance:white powder
Storage:2-8°
Purity: ≥99%

Please note that all products featured here are intended exclusively for research and development purposes. They are not designed for any form of human consumption. These products have not undergone evaluation by the U.S. Food and Drug Administration.

View Test Certificate

 

Vector

Gently clarifies pores

Vector

Soothes sensitive skin

Vector

Dermatologist tested

Pay safely with Visa Pay safely with Master Card Pay safely with PayPal Pay safely with American Express Pay safely with Maestro
Guarantee Safe and Secure Payment Checkout
Elite Edge Biotech Tirzepatide 5mg vial, GIP/GLP-1 dual agonist research peptide Tirzepatide | (GIP/GLP-1 Dual ...

Price range: $41 through $300

Select options

What is Research Peptide Tirzepatide?

Research peptide Tirzepatide is a synthetic dual agonist of GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). It has shown strong potential in studies related to weight loss, fat burning, and insulin sensitivity. As a next-gen compound, it’s being widely evaluated in metabolic and obesity-focused research.

This Tirzepatide peptide is not approved for human use and is sold strictly for laboratory research.

Tirzepatide Specifications

  • Purity: 99.6–99.9%
  • Available Doses:
    • 6.56 mg (5 mg)
    • 13.24 mg (12 mg)
    • 18.55 mg (15 mg)
    • 24.00 mg (20 mg)
    • 34.22 mg (30 mg)
    • 43.97 mg (40 mg)
    • 62.39 mg (60 mg)

  • CAS NO: 2023788-19-2
  • Molecular Formula: C225H348N48O68
  • Molecular Weight: 4813.53 Da
  • Appearance: White Lyophilized Powder
  • Storage: 2–8°C
  • Use: For research only

Potential Research Benefits of Tirzepatide

Studies using Tirzepatide research peptides have explored several metabolic and physiological outcomes:

  • Supports fat metabolism and weight loss
  • May improve insulin response and glucose regulation
  • Investigated for use in obesity and diabetes research
  • Combines GIP + GLP-1 activity for synergistic effects

If you’ve wondered, “Does tirzepatide burn fat?”, current research supports its promising role in lipolysis and body weight reduction, especially in preclinical models.

Elite Edge Biotech Tirzepatide 5mg vial, GIP/GLP-1 dual agonist research peptide
Elite Edge Biotech Tirzepatide 5mg vial, GIP/GLP-1 dual agonist research peptide

Tirzepatide Dosage Chart (For Lab Use)

Research studies typically test tirzepatide peptide 10mg, 20mg, or 60mg, depending on the model. Refer to a Tirzepatide dosage chart and your protocol for proper handling and measurement. This peptide is supplied in a sterile, research-ready form.

⚠️ This compound is intended for research purposes only. Not for human consumption.

Why Buy Tirzepatide from Elite Edge Biotech?

When you buy research peptide Tirzepatide from Elite Edge Biotech, you receive:

  • COA-backed purity (≥99.6%)
  • Secure shipping with temperature-safe packaging
  • Multiple size options, including 10mg, 20mg, and 60mg
  • Trusted U.S.-based source for research peptide,s Tirzepatide
  • Competitive pricing forthe  cheapest Tirzepatide online

Looking for Tirzepatide near me? We ship fast nationwide with discreet handling.

 

Popular Questions

Is Tirzepatide oral?

Oral tirzepatide forms are in development, but injectable research versions like ours are standard in laboratories.

Switching from Semaglutide to Tirzepatide?

Some studies explore switching from semaglutide to tirzepatide to evaluate differences in metabolic impact and efficacy.

Retatrutide vs Tirzepatide – what’s the difference?

Retatrutide is a newer triple agonist, while Tirzepatide remains a dual GIP/GLP-1 agonist. Research is ongoing to compare outcomes.

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide | (GIP/GLP-1 Dual Agonist)”

Your email address will not be published. Required fields are marked

*Please note that all products featured here are intended exclusively for research and development purposes. They are not designed for any form of human consumption. These products have not undergone evaluation by the U.S. Food and Drug Administration.